Clinical Trial Update: Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing continuous versus fixed-duration therapy with daratumumab, lenalidomide, and dexamethasone in relapsed multiple myeloma. The trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• Decadron (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Multiple Myeloma in Relapse | Phase 3 | Status: ACTIVE_NOT_RECRUITING